Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 1992; Volume 20,Issue 5
  • You have access
    Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and beta-naphthoflavone.
    I U Khan, D R Bickers, T M Haqqi and H Mukhtar
    Drug Metabolism and Disposition September 1992, 20 (5) 620-624;
  • You have access
    Conjugation of dinitrofluorobenzene to plasma proteins in vivo in the rat.
    N R Kitteringham, J G Kenna, C McLean, J B Clarke and B K Park
    Drug Metabolism and Disposition September 1992, 20 (5) 625-631;
  • You have access
    Isolation, purification, and characterization of two new chemical decomposition products of methylazoxyprocarbazine.
    D S Swaffar, W G Harker, S C Pomerantz, H K Lim and G S Yost
    Drug Metabolism and Disposition September 1992, 20 (5) 632-642;
  • You have access
    Effects of dose, strain, and dosing vehicle on methacrylonitrile disposition in rats and identification of a novel-exhaled metabolite.
    B I Ghanayem, I M Sanchez and L T Burka
    Drug Metabolism and Disposition September 1992, 20 (5) 643-652;
  • You have access
    Pharmacokinetics and renal handling of enprofylline in pregnant rats.
    I Muraoka, T Hasegawa, M Nadai, K Kato and T Nabeshima
    Drug Metabolism and Disposition September 1992, 20 (5) 653-657;
  • You have access
    Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Possible role in 1,3-butadiene-induced toxicity.
    J E Sharer, R J Duescher and A A Elfarra
    Drug Metabolism and Disposition September 1992, 20 (5) 658-664;
  • You have access
    Identification and comparison of the urinary metabolites of [1,2,3-13C3]acrylic acid and [1,2,3-13C3]propionic acid in the rat by homonuclear 13C nuclear magnetic resonance spectroscopy.
    S M Winter, G L Weber, P R Gooley, N E MacKenzie and I G Sipes
    Drug Metabolism and Disposition September 1992, 20 (5) 665-672;
  • You have access
    Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Y Kido, A R Khokhar and Z H Siddik
    Drug Metabolism and Disposition September 1992, 20 (5) 673-678;
  • You have access
    Disposition of acrivastine in the male beagle dog.
    M J McNulty, D L Deal, F R Nelson, S Weller, P Chandrasurin, J Shockcor and J W Findlay
    Drug Metabolism and Disposition September 1992, 20 (5) 679-687;
  • You have access
    Bromo(monohydroxy)phenyl mercapturic acids. A new class of mercapturic acids from bromobenzene-treated rats.
    J Zheng and R P Hanzlik
    Drug Metabolism and Disposition September 1992, 20 (5) 688-694;
  • You have access
    Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
    C B Davis, K E Boyle, J J Urbanski, R T Paradysz and K L Fong
    Drug Metabolism and Disposition September 1992, 20 (5) 695-705;
  • You have access
    Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.
    L B Grochow, E K Rowinsky, R Johnson, S Ludeman, S H Kaufmann, F L McCabe, B R Smith, L Hurowitz, A DeLisa and R C Donehower
    Drug Metabolism and Disposition September 1992, 20 (5) 706-713;
  • You have access
    Exogenous glutathione decreases cellular cadmium uptake and toxicity.
    Y J Kang
    Drug Metabolism and Disposition September 1992, 20 (5) 714-718;
  • You have access
    Enantioselectivity of microsomal and cytosolic esterases in rat intestinal mucosa.
    S K Yang, Y Y Hsieh, W C Chang and J D Huang
    Drug Metabolism and Disposition September 1992, 20 (5) 719-725;
  • You have access
    Concomitant induction of microsomal epoxide hydrolase and UDP-glucuronosyltransferase activities by dipyridine compounds.
    M R Franklin and D E Moody
    Drug Metabolism and Disposition September 1992, 20 (5) 726-729;
  • You have access
    Comparative pharmacokinetics of cefoperazone and cephradine in untreated streptozotocin diabetic rats.
    E Nakashima, R Matsushita, M Takeda, T Nakanishi and F Ichimura
    Drug Metabolism and Disposition September 1992, 20 (5) 730-735;
  • You have access
    The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
    O R Epemolu, S Singh, R C Hider and L A Damani
    Drug Metabolism and Disposition September 1992, 20 (5) 736-741;
  • You have access
    Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage.
    G Grosa, O Caputo, M Ceruti and G Biglino
    Drug Metabolism and Disposition September 1992, 20 (5) 742-746;
  • You have access
    Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
    L Naesens, J Balzarini and E De Clercq
    Drug Metabolism and Disposition September 1992, 20 (5) 747-752;
  • You have access
    Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.
    M Sattler, F P Guengerich, C H Yun, U Christians and K F Sewing
    Drug Metabolism and Disposition September 1992, 20 (5) 753-761;
  • You have access
    Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination.
    J Turgeon, J R Paré, M Lalande, O Grech-Bélanger and P M Bélanger
    Drug Metabolism and Disposition September 1992, 20 (5) 762-769;
  • You have access
    Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat.
    J A Ruzicka and P C Ruenitz
    Drug Metabolism and Disposition September 1992, 20 (5) 770-772;
  • You have access
    Trimethadione metabolism as an index of hepatic drug-oxidizing capacity in dogs with liver ischemia.
    E Tanaka, M Otsuka, K Yuzawa, A Isikawa, K Fukao and Y Iwasaki
    Drug Metabolism and Disposition September 1992, 20 (5) 773-774;
  • You have access
    Inhibition of rabbit microsomal cytochrome P-450 2E1-dependent p-nitrophenol hydroxylation by substituted benzene derivatives.
    D R Koop and C L Laethem
    Drug Metabolism and Disposition September 1992, 20 (5) 775-777;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 20, Issue 5
1 Sep 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics